Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers DOI Creative Commons
Jazmín Torres,

Johanna Karina Valenzuela Oses,

A. M. Rabasco

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(2), P. 245 - 245

Published: Feb. 13, 2025

Recent advancements in nanotechnology have revolutionized cancer therapy-one of the most pressing global health challenges and a leading cause death-through development liposomes (L), lipid-based nanovesicles known for their biocompatibility ability to encapsulate both hydrophilic lipophilic drugs. More recent innovations led creation stimuli-responsive L that release payloads response specific endogenous or exogenous triggers. Dual- multi-responsive L, which react multiple stimuli, offer even greater precision, improving therapeutic outcomes while reducing systemic toxicity. Additionally, these smart can adjust physicochemical properties morphology enable site-specific targeting controlled drug release, enhancing treatment efficacy minimizing adverse effects. This review explores latest liposomal nanocarriers, as well dual- integrate internal external triggers, with focus on design strategies, mechanisms, applications therapy.

Language: Английский

Advancements in Protein-Based Bionanocomposites for Targeted and Controlled Drug Delivery Systems: A Comprehensive Review DOI
Dahlang Tahir,

Syarifuddin Syarifuddin,

E Noor

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106698 - 106698

Published: Feb. 1, 2025

Language: Английский

Citations

0
Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers DOI Creative Commons
Jazmín Torres,

Johanna Karina Valenzuela Oses,

A. M. Rabasco

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(2), P. 245 - 245

Published: Feb. 13, 2025

Recent advancements in nanotechnology have revolutionized cancer therapy-one of the most pressing global health challenges and a leading cause death-through development liposomes (L), lipid-based nanovesicles known for their biocompatibility ability to encapsulate both hydrophilic lipophilic drugs. More recent innovations led creation stimuli-responsive L that release payloads response specific endogenous or exogenous triggers. Dual- multi-responsive L, which react multiple stimuli, offer even greater precision, improving therapeutic outcomes while reducing systemic toxicity. Additionally, these smart can adjust physicochemical properties morphology enable site-specific targeting controlled drug release, enhancing treatment efficacy minimizing adverse effects. This review explores latest liposomal nanocarriers, as well dual- integrate internal external triggers, with focus on design strategies, mechanisms, applications therapy.

Language: Английский

Citations

0